v3.25.1
Related Party Transactions
 3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions
(19)Related party transactions

 

As of March 31, 2025, the Group’s related parties are as follows:

 

Type   Related parties
Ultimate parent entity   Bellevue Capital Management LLC
Major shareholder of the Parent   BCM Europe AG
Subsidiaries   RSM, VAXIMM, Darnatein, OSR Holdings, Inc.
Associates   Taction Co., Ltd.
Other related parties   Bellevue Global Life Sciences Investors LLC

 

There are no sales and procurement transactions and treasury transactions with related parties for the three-months ended March 31, 2025 and 2024. The Group acquired Vaximm from BCM Europe AG in December 2022 (Transaction between entities under common control), which is disclosed in detail in Note 27 Business combinations.

 

Details of receivables and payables from related party transactions as at March 31, 2025 and December 31, 2024 are as follows:

 

   March 31, 2025
   Related parties  Short-term borrowings 
Key management  Individuals  $641,323 
Bellevue Global Life Sciences Acquisition Corp  Other related parties  $300,716 
Bellevue Capital Management Europe AG  Major shareholder of the Parent  $862,053 

 

   December 31, 2024
   Related parties   Short-term borrowings
Key management  Individuals  $340,136

Compensations paid or accrued to key management of the Parent for the three months ended March 31, 2025 and 2024 are as follows:

 

   For the three-month ended 
   March 31, 2025   March 31, 2024 
Salaries  $80,701   $104,344 

 

The Group’s key management includes registered directors who have important authority and responsibility for planning, operation, and control of the Group’s business activities.

 

No collateral or guarantee were provided for related parties and were received from related parties as of March 31, 2025 and December 31, 2024.